社区医生2型糖尿病管理流程与分级诊疗规范(深圳专家共识)

2018-03-30 中国内分泌相关专家小组(统称) 中华全科医学杂志.2018.21(11):1261-1269.

《社区医生2 型糖尿病管理流程与分级诊疗规范(深圳专家共识)》的制定,引用了国内外专业领域相关糖尿病指南、专家共识,以及重要循证医学研究作为参考依据,并对这些证据予以分类并赋予等级,质量可靠。该共识结合深圳市的区域特点和要求,与当地社区诊疗实践相结合,提出在深圳社区实际存在的问题以及有针对性的解决方案,内容比较具体、全面,总体具有可操作性。因此,该共识对社区医生进行2 型糖尿病管理具有较好的指导意

中文标题:

社区医生2型糖尿病管理流程与分级诊疗规范(深圳专家共识)

发布日期:

2018-03-30

简要介绍:

《社区医生2 型糖尿病管理流程与分级诊疗规范(深圳专家共识)》的制定,引用了国内外专业领域相关糖尿病指南、专家共识,以及重要循证医学研究作为参考依据,并对这些证据予以分类并赋予等级,质量可靠。该共识结合深圳市的区域特点和要求,与当地社区诊疗实践相结合,提出在深圳社区实际存在的问题以及有针对性的解决方案,内容比较具体、全面,总体具有可操作性。因此,该共识对社区医生进行2 型糖尿病管理具有较好的指导意义,社区医生在工作中可以充分借鉴参考。同时应注意个体化诊疗,对患者的病情和特点进行全面的个体化评估,掌握好双向转诊的标准和要求,充分发挥自身优势以及与专[科医生的协同作用,以全程安全有效管理糖尿病。

 

拓展指南:糖尿病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=社区医生2型糖尿病管理流程与分级诊疗规范(深圳专家共识))] GetToolGuiderByIdResponse(projectId=1, id=ff53a1c001583341, title=社区医生2型糖尿病管理流程与分级诊疗规范(深圳专家共识), enTitle=, guiderFrom=中华全科医学杂志.2018.21(11):1261-1269., authorId=null, author=, summary=《社区医生2 型糖尿病管理流程与分级诊疗规范(深圳专家共识)》的制定,引用了国内外专业领域相关糖尿病指南、专家共识,以及重要循证医学研究作为参考依据,并对这些证据予以分类并赋予等级,质量可靠。该共识结合深圳市的区域特点和要求,与当地社区诊疗实践相结合,提出在深圳社区实际存在的问题以及有针对性的解决方案,内容比较具体、全面,总体具有可操作性。因此,该共识对社区医生进行2 型糖尿病管理具有较好的指导意, cover=, journalId=null, articlesId=null, associationId=666, associationName=中国内分泌相关专家小组(统称), associationIntro=这是一个统称,其下指南和专家共识均由国内内分泌领域的专家制定。, copyright=0, guiderPublishedTime=Fri Mar 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>《社区医生2 型糖尿病管理流程与分级诊疗规范(深圳专家共识)》的制定,引用了国内外专业领域相关糖尿病指南、专家共识,以及重要循证医学研究作为参考依据,并对这些证据予以分类并赋予等级,质量可靠。该共识结合深圳市的区域特点和要求,与当地社区诊疗实践相结合,提出在深圳社区实际存在的问题以及有针对性的解决方案,内容比较具体、全面,总体具有可操作性。因此,该共识对社区医生进行2 型糖尿病管理具有较好的指导意义,社区医生在工作中可以充分借鉴参考。同时应注意个体化诊疗,对患者的病情和特点进行全面的个体化评估,掌握好双向转诊的标准和要求,充分发挥自身优势以及与专[科医生的协同作用,以全程安全有效管理糖尿病。</P> <P> </P>拓展指南:<strong>与<font color=red>糖尿病</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=9bfcd1c0015686af" title="2017 RSSDI临床实践建议:2型糖尿病的管理" target=_blank>2017 RSSDI临床实践建议:2型糖尿病的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ce39a1c00156e9b2" title="基层糖尿病微血管病变筛查与防治专家共识" target=_blank>基层糖尿病微血管病变筛查与防治专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a82c61c00156e0c7" title="2018 HFA/ESC立场声明:2型糖尿病和心衰" target=_blank>2018 HFA/ESC立场声明:2型糖尿病和心衰</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0917a1c001566618" title="中国2型糖尿病防治指南(2017年版)" target=_blank>中国2型糖尿病防治指南(2017年版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=549471c001558936" title="2018 台湾2型糖尿病合并心血管疾病患者药物管理共识" target=_blank>2018 台湾2型糖尿病合并心血管疾病患者药物管理共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=28103, tagName=社区医生), TagDto(tagId=2052, tagName=2型糖尿病), TagDto(tagId=25959, tagName=分级诊疗)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6774, appHits=435, showAppHits=15, pcHits=4819, showPcHits=2033, likes=148, shares=14, comments=5, approvalStatus=1, publishedTime=Tue Apr 24 22:14:12 CST 2018, publishedTimeString=2018-03-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 24 22:14:12 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 02:36:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=社区医生2型糖尿病管理流程与分级诊疗规范(深圳专家共识))])
社区医生2型糖尿病管理流程与分级诊疗规范(深圳专家共识)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222333, encodeId=5299122233360, content=谢谢分享 非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed May 25 15:09:13 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222552, encodeId=baed12225525f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 10:27:31 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348505, encodeId=cf91348505b1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=784e2456578, createdName=124078f9m49暂无昵称, createdTime=Mon Oct 08 17:25:08 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309620, encodeId=822a3096201e, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:56 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2022-05-25 ms4000000901131801

    谢谢分享 非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222333, encodeId=5299122233360, content=谢谢分享 非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed May 25 15:09:13 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222552, encodeId=baed12225525f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 10:27:31 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348505, encodeId=cf91348505b1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=784e2456578, createdName=124078f9m49暂无昵称, createdTime=Mon Oct 08 17:25:08 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309620, encodeId=822a3096201e, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:56 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2022-05-26 ms4000000901131801

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222333, encodeId=5299122233360, content=谢谢分享 非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed May 25 15:09:13 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222552, encodeId=baed12225525f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 10:27:31 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348505, encodeId=cf91348505b1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=784e2456578, createdName=124078f9m49暂无昵称, createdTime=Mon Oct 08 17:25:08 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309620, encodeId=822a3096201e, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:56 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2018-10-08 124078f9m49暂无昵称

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222333, encodeId=5299122233360, content=谢谢分享 非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed May 25 15:09:13 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222552, encodeId=baed12225525f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 10:27:31 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348505, encodeId=cf91348505b1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=784e2456578, createdName=124078f9m49暂无昵称, createdTime=Mon Oct 08 17:25:08 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309620, encodeId=822a3096201e, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:56 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2018-04-27 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0